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Acute Wounding Alters the Beta2-Adrenergic
Signaling and Catecholamine Synthetic Pathways
in Keratinocytes
Raja K. Sivamani1, Biao Shi1, Elizabeth Griffiths1, Shirley M. Vu1, Hadar A. Lev-Tov1,2, Sara Dahle3,
Marianne Chigbrow1, Thi Dinh La1, Chelcy Mashburn4, Thomas R. Peavy4 and R. Rivkah Isseroff1,2
Keratinocyte migration is critical for wound re-epithelialization. Previous studies showed that epinephrine
activates the beta2-adrenergic receptor (B2AR), impairing keratinocyte migration. Here, we investigated the
keratinocyte catecholamine synthetic pathway in response to acute trauma. Cultured keratinocytes were scratch
wounded and expression levels of the B2AR and catecholamine synthetic enzymes tyrosine hydroxylase and
phenylethanolamine-N-methyltransferase were assayed. The binding affinity of the B2AR was measured.
Wounding downregulated B2AR, tyrosine hydroxylase, and phenylethanolamine-N-methyltransferase expression,
but pre-exposure to timolol, a beta-adrenergic receptor antagonist, delayed this effect. In wounded keratinocytes,
B2AR-binding affinity remained depressed even after its expression returned to prewounding levels. Keratino-
cyte-derived norepinephrine increased after wounding. Norepinephrine impaired keratinocyte migration; this
effect was abrogated with B2AR-selective antagonist ICI-118,551 but not with B1AR-selective antagonist bisoprolol.
Finally, for clinical relevance, we determined that norepinephrine was present in freshly wounded skin, thus
providing a potential mechanism for impaired healing by local B2AR activation in wound-edge keratinocytes.
Taken together, the data show that keratinocytes modulate catecholamine synthetic enzymes and release
norepinephrine after scratch wounding. Norepinephrine appears to be a stress-related mediator that impairs
keratinocyte migration through activation of the B2AR. Future therapeutic strategies evaluating modulation of
norepinephrine-related effects in the wound are warranted.
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INTRODUCTION
The directed migration of keratinocytes is critical to wound
re-epithelialization and is controlled by many factors (reviewed
in (Santoro and Gaudino, 2005; Sivamani et al., 2007)).
One important modulator is the beta-adrenergic receptor.
The beta-adrenergic receptor signaling system has an
important role in epidermal wound physiology. Activation
of the beta2-adrenergic receptor (B2AR) delays epidermal
barrier repair, whereas blockade of this receptor increases it
(Denda et al., 2003). Furthermore, isoproterenol, a synthetic
pharmacological agonist for the (B2AR) decreases keratinocyte
migratory speed, reduces in vitro scratch-wound closure, and
delays ex vivo human wound re-epithelialization (Pullar et al.,
2003, 2006a). Conversely, blockade of the keratinocyte
B2AR increases migratory speed and accelerates wound
re-epithelialization (Pullar et al., 2006b; Sivamani et al.,
2009b; Pullar et al., 2012). Thus, wound re-epithelialization
can be modulated through the B2AR through its control of
keratinocyte migration. Catecholamines are the endogenous
agonists for the adrenergic family of receptors and epinephrine
has the highest selectivity and affinity for the B2AR (Stiles
et al., 1984; Frielle et al., 1988). Earlier work has demon-
strated that epinephrine inhibits keratinocyte migration
through the B2AR (Donaldson and Mahan, 1984) and more
recent work has shown that keratinocytes themselves possess
the enzymes necessary for the synthesis of epinephrine
(Schallreuter et al., 1992; Pullar et al., 2006b; Sivamani
et al., 2009b), providing the potential for an autocrine
inhibitory loop.
Stress, such as UVB irradiation (Iizuka et al., 1985; Chai
et al., 1996) or thermal injury (Sivamani et al., 2009b) modu-
lates keratinocyte expression of B2AR and cyclic AMP. How-
ever, acute (non-thermal) wounding of the skin is much more
common, and the effects of this trauma on catecholamine
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generation, B2AR expression, pathway signaling, and healing
of the epidermis has not been studied. Assays that evaluate the
en masse movement of sheets of cells from the free edge, such
as the scratch-wound assay, have served as a surrogate for
investigating the modulation of wound healing (Sivamani
et al., 2009b; Melchionna et al., 2012; Meyer et al., 2012;
Rotty and Coulombe, 2012; Shibata et al., 2012; Chen et al.,
2013; Pan et al., 2013) and was utilized here to fill the
information gap regarding the influence of catecholamines
and the B2AR in epithelial wound healing.
RESULTS
Keratinocytes decrease B2AR expression in response to
wounding
Confluent keratinocyte monolayers were scratch wounded
and assessed for the expression of the B2AR at various times
after scratch wounding. Keratinocytes decreased B2AR expres-
sion by 1hour after wounding, but this expression recovered
toward unwounded levels by 6hours after wounding
(Figure 1a). Downregulation of the B2AR is well described
in response to ligand binding of the B2AR (Shenoy et al.,
2001; Johnson, 2006), but it should be noted that this
downregulation occurred in the absence of exogenously
added epinephrine. However, keratinocytes can synthesize
epinephrine (Schallreuter et al., 1992; Pullar et al., 2006b) that
could be responsible for the observed downregulation. We
therefore investigated whether this downregulation of the
B2AR could be delayed by incubating the scratch wounds
with a beta-adrenergic antagonist. We incubated keratinocytes
with 10mM timolol, a non-specific BAR antagonist, to block
the B2AR. The addition of timolol delayed the downregulation
of B2AR expression (Figure 1b).
Scratch wounding decreases the affinity of the keratinocyte BAR
Keratinocytes in confluent cultures that were scratch wounded
showed decreased affinity of the beta-adrenergic receptor at
24hours after wounding as evidenced by binding affinity
curves and a Scatchard plot (Figure 2a and b). The overall
binding sites increased from control, Bmax¼32.44, to 24hours
post-scratch, Bmax¼52.01 (Figure 2c). The overall binding
affinity decreased from control, Kd¼ 0.2862, to 24hours post-
scratch, Kd¼0.43 (Figure 2c).
Keratinocytes decrease synthesis of catecholamines in response
to scratch wounding
Previous reports have shown that keratinocytes express
enzymes necessary for the synthesis of catecholamines
(Schallreuter et al., 1992; Pullar et al., 2006b; Sivamani
et al., 2009a, 2009b) and we investigated how scratch
wounding modulates the expression of these enzymes.
Among the catecholamines, epinephrine has a much greater
affinity for the B2AR in comparison to norepinephrine.
As such, we investigated the expression of both tyrosine
hydroxylase (TH), which is the rate-limiting enzyme in the
catecholamine synthesis pathway, and phenylethanolamine-
N-methyltransferase (PNMT), which is the enzyme required
for the final conversion of norepinephrine into epinephrine.
We observed that both TH and PNMT transiently decreased by
1hour after scratch wounding and returned to baseline
expression by 24hours (Figure 3a and b), similar to the
B2AR. The addition of timolol-abrogated modulation of TH
expression and delayed the decrease in PNMT expression
such that it decreased at 2 hours instead of at 1 hour after the
scratch wound (Figure 3c and d). Both TH and PNMT
expression decreased during the post-scratch time in a similar
fashion as the B2AR expression (compare with Figure 1).
Scratch wounding increases extracellular epinephrine and
norepinephrine levels
After scratch wounding, epinephrine levels in the medium did
not change after 24hours (Figure 4a). However, norepi-
nephrine levels were elevated at 1 hour and approximately
3.7-fold at 24hours after scratch wounding (Figure 4b). To
assess for the breakdown product of epinephrine and norepi-
nephrine, we assayed for the levels of 3,4-dihydroxyphenyl-
ethylene glycol (DOPEG) and found that this compound
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Figure 1. Keratinocyte beta2-adrenergic receptor (B2AR) expression transiently decreases after scratch wounding. (a) Confluent keratinocyte cultures were
scratch-wounded and allowed to recover in keratinocyte growth medium. The expression of the beta2AR (B2AR) was monitored over time and was decreased
by 30minutes after wounding. Expression of the B2AR recovered toward control keratinocyte expression levels by 6 and 24hours after wounding. (b) Pretreatment
with 10mM timolol (betaAR antagonist) delayed the decrease in B2AR expression in response to scratch wounding to 2 hours, with no evidence of
recovery of B2AR expression by 24hours. Unscratched confluent keratinocytes served as controls (C). (c) Graphical depiction of the timeline for the decrease
of B2AR with and without timolol. Data are representative of three repeat experiments in two different keratinocyte strains. Similar temporal results were
obtained in the two strains examined. Error bars represent mean±SEM; *Po0.01; **Po0.05.
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was 2.2-fold increased at 1 hour and 1.9-fold increase at
24hours after wounding (Figure 4b), suggesting potential
metabolic breakdown of released epinephrine to this
compound.
Scratch wounding decreases intracellular epinephrine and
norepinephrine levels
Both epinephrine and norepinephrine were at the highest
intracellular levels prior to wounding and then subsequently
decreased 30minutes and 1hour after wounding (Figure 4b).
However, intracellular levels of epinephrine and norepi-
nephrine both began to increase again by 24hours. No
intracellular DOPEG was detected.
Norepinephrine reduces keratinocyte motility via the B2AR
Norepinephrine reduced keratinocyte cell motility in a
dose-dependant manner (Figure 5a). The cells were then
co-incubated with selective B1AR or B2AR antagonists
to further evaluate norepinephrine’s BAR-mediated effects.
Co-incubation of the selective B1AR antagonist bisoprolol
did not mitigate norepinephrine-induced reduction in kerati-
nocyte motility (Figure 5b). However, co-incubation with the
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Figure 2. Scratch wounding decreases the affinity of the keratinocyte beta-adrenergic receptor for its ligand. (a) Confluent keratinocytes were scratch wounded
and then collected at 6 and 24hours after wounding. The cells were exposed to [3H]-CGP12177, a radionuclide and beta-adrenergic receptor ligand, in the
absence (total binding) or presence of 5mM propranolol (non-specific binding). (b) Binding saturation curves were linearized by plotting the bound radioligand to
unbound radioligand against the bound ligand concentration. The linear curves were generated with a least-squares fit to the data. The data represent the results of
three replicates. (c) Keratinocytes had decreased binding affinity for the beta-adrenergic receptor ligand 24hours after wounding in comparison with control
unwounded keratinocytes or keratinocytes 6 hours after wounding. Error bars represent mean±SEM.
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Figure 3. Scratch wounding transiently decreases keratinocyte expression of catecholamine-synthesizing enzymes and is delayed by timolol (betaAR antagonist).
Confluent keratinocytes were scratch wounded and allowed to recover in keratinocyte growth medium. (a) Tyrosine hydroxylase (TH), the rate-limiting enzyme
of the catecholamine synthesis pathway, decreased in expression by 30minutes after scratch wounding. By 6hours after scratch wounding, the expression
of TH returned to baseline. (b) The expression of phenylethanolamine-N-methyl transferase (PNMT), the enzyme required for the synthesis of epinephrine,
decreased by 1hour, in a similar manner as the TH expression. PNMT expression returned toward baseline by 24hours after scratch wounding. Unscratched
confluent keratinocytes served as controls (C). (c) Confluent keratinocytes were scratch wounded and allowed to recover in keratinocyte growth medium
incubated with 10mM timolol. Pretreatment with timolol completely abrogates any modulation of the TH expression after scratch wounding. (d) The presence of
timolol delays and mitigates the downregulation of PNMT. Unscratched confluent keratinocytes served as controls (C). Data are representative of two repeat
experiments in at least two different keratinocyte strains.
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selective B2AR antagonist ICI-118,551 abrogated norepi-
nephrine-mediated reduction in keratinocyte motility
(Figure 5b).
Noerpinephrine is present in human cutaneous wounds
Human skin tissue from acutely generated surgical wounds
was harvested within 30minutes of surgical wounding from
five different donors, and processed for extraction and quanti-
fication of catecholamines. Norepinephrine was present in the
wounds (Figure 5c).
DISCUSSION
The catecholamine network and the B2AR have an important
role in keratinocyte wound-healing physiology (reviewed
in (Sivamani et al., 2007)). Activation of the B2AR delays
epidermal barrier homeostasis (Denda et al., 2003), reduces
keratinocyte motility (Pullar et al., 2003), and delays wound
re-epithelialization (Pullar et al., 2006a). Conversely, blockade
of the B2AR leads to increased keratinocyte motility
and accelerates wound re-epithelialization (Pullar et al.,
2006b; Sivamani et al., 2009b). Notably, blockade of
the B2AR increases keratinocyte motility and wound
re-epithelialization even in the absence of an exogenous
agonist, suggesting an autocrine mechanism for activation
of the keratinocyte B2AR (Pullar et al., 2006b; Sivamani et al.,
2009b). Indeed, keratinocytes possess the capacity to
synthesize catecholamines (Schallreuter et al., 1992; Pullar
et al., 2006b), providing the potential for a negative feedback
loop.
Here, we used the wounding of a confluent sheet of human
keratinocytes as the experimental paradigm in which to
evaluate the effects of acute wounding of the epidermis on
the B2AR pathway. In doing so, we demonstrate the utility of
the scratch-wound assay to model epithelial wound healing,
similar to previous investigations (Sivamani et al., 2009b;
Melchionna et al., 2012; Meyer et al., 2012; Rotty and
Coulombe, 2012; Shibata et al., 2012; Chen et al., 2013).
We show that cultured keratinocytes transiently reduce their
expression of the B2AR and that the B2AR has decreased
affinity for its ligand in response to scratch wounding.
As activation of the B2AR decreases migratory rate, the
downregulation of the B2AR expression and affinity could
represent a negative feedback mechanism where keratinocytes
shift to a pro-migratory phenotype. Our finding that the
keratinocyte BAR has lowered affinity for its ligand even
when levels have returned to pre-scratch levels at 24hours
further support that keratinocytes have shifted into a pro-
migratory phenotype. This is in agreement with previous
reports that have shown that keratinocytes respond to
scratch wounding by transiently shifting to a more migratory
phenotype through upregulation of multiple genes such as
BCAR3 and MAP4K, although the influence of the B2AR was
not noted (Fitsialos et al., 2007). We observed that blockade
of the B2AR delays its downregulation, highly suggestive of
a negative feedback mechanism involving activation of this
receptor.
Our results also demonstrate that norepinephrine is an
important component of the acute in vitro epithelial wound
microenvironment. Norepinephrine levels were increased by
1hour after wounding keratinocyte sheets and markedly
increased 24hours after wounding. In addition to epinephrine,
norepinephrine binds, activates, and modulates the expression
of the B2AR (Swaminath et al., 2004; Wang et al., 2008; Weitl
and Seifert, 2008; Reiner et al., 2010; Masuda et al., 2012). In
this study, we noted that at 24 hours after wounding, the
norepinephrine levels were an order of magnitude (14-fold)
higher than epinephrine levels, and may contribute to B2AR
stimulation, especially as keratinocytes have been shown
to relatively express almost 100-fold less B1AR than B2AR
(Steenhuis et al., 2011). Interestingly, although previous work
has focused on effects of synthetic catecholamines (e.g.,
isoproterenol), our finding is of particular significance in we
demonstrate that keratinocytes are able to modulate B2AR
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Figure 4. Scratch wounding leads to the release of catecholamines.
(a) Scratch wounding of confluent normal human keratinocytes (NHKs)
leads to the release of norepinephrine and 3,4-dihydroxyphenylethylene
glycol (DOPEG), a breakdown product of epinephrine and norepinephrine,
at 1 hour and 24hours after scratching. However, no change in epinephrine
was measured in the supernatant. (b) Intracellular catecholamines. No
intracellular DOPEG was measured. Epi, epinephrine; Nor, norepinephrine;
DOPEG, 3,4-dihydroxyphenylethylene glycol. *Po0.01; #Po0.05. The units
pgmg protein1 refers to pg per mg of cellular protein. Error bars represent
mean±SEM; n¼4 samples from two different keratinocyte strains.
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expression through an autocrine mechanism involving the
activation of the B2AR with endogenously generated
norepinephrine. Our results are likely not limited to skin
keratinocytes, as other epithelia, such as the corneal and oral
epithelium predominantly express B2AR (Ghoghawala et al.,
2008; Steenhuis et al., 2011). As norepinrphine is also found
in these tissues (Murphy et al., 1998; Kennedy et al., 2001;
Ghoghawala et al., 2008; Steenhuis et al., 2011), it is quite
possible that norepinephrine has a significant role in wound
healing of these epithelia as well. Additional studies are
needed to evaluate this possibility.
Activation-mediated downregulation of B2AR is a well-
known phenomenon (Barak and Caron, 1995). Although
keratinocytes are capable of synthesizing epinephrine (Pullar
et al., 2006b; Sivamani et al., 2009b), an endogenous ligand
to the B2AR, it is unclear which population of keratinocytes is
responsible for the release of the B2AR ligand in the scratch-
wound assay. Several populations of keratinocytes are present
in the scratch wound including those that are acutely injured
during the scratch wound and the cells that are found away
from the wound edge that were not directly injured by the
scratch wound itself. It remains to be determined whether the
acutely injured cells or the cells at the wound edge are
responsible for the release of the keratinocyte-secreted B2AR
ligand. In the particular assay used in this study, the majority
of the damaged cells were removed as part of the scratch
wounding procedure, and our subsequent analyses are more
likely representative of the physiological responses of the
wound-edge keratinocytes rather than the acutely injured
keratinocytes. Regardless, our results clearly show that B2AR
expression is modulated through activation of the receptor.
Interestingly, we found that blockade of the B2AR delayed
but did not completely block downregulation of the B2AR,
suggesting that a mechanism independent of activation of the
receptor may also be involved in downregulation of the B2AR.
Indeed, keratinocytes have previously been shown to decrease
their expression of the B2AR in response to chemical irritation
(Chang et al., 1998) or ultraviolet injury (Chai et al., 1996).
A similar B2AR-independent injury-related mechanism may
be involved in the late decrease in B2AR expression.
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Figure 5. Norepinephrine reduces the migratory rate of cultured keratinocytes via the beta2-adrenergic receptor (B2AR) and is found in human wounds.
(a) Norepinephrine impairs single-cell migration in a dose-dependent manner. *Po0.01; n¼ 40. Data are representative of triplicate experiments in two strains.
(b) To test for receptor-specific-mediated effects, experiments were performed where 10mM of norepinephrine (NE) was either co-incubated with the
B1AR-selective antagonist, 10mM bisoprolol (Bis), or with the B2AR-selective antagonist, 10mM ICI-118,551 (ICI). The addition of bisoprolol did not reverse
the impaired motility induced by norepinephrine. However, the addition of ICI-118,551, reversed the impaired motility induced by NE. *Po0.01; n¼ 45. Data are
representative of triplicate experiments in two strains. (c) Tissue collected from human skin wounds revealed the presence of norepinephrine. Norepinephrine
amounts were normalized to the weight of removed wound tissue. n¼ 5 wounds from five different individuals. Error bars represent mean±SEM.
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We found that the changes in the expression of the
catecholamine synthetic enzymes, TH and PNMT, followed
the pattern of modulation of the B2AR. Our results suggest that
expression of the B2AR is important for TH and PNMT
expression. In agreement with this, basal and inducible TH
transcription is regulated by a cAMP response element (Kim
et al., 1993; Sabban, 1997; Lim et al., 2000; Lewis-Tuffin
et al., 2004). Increases in cAMP, irrespective of the inducing
stimuli, lead to increased TH expression (Pliego Rivero et al.,
1999; Lewis-Tuffin et al., 2004; DeCastro et al., 2005;
Maharjan et al., 2005). Also, it has been shown that
increases in intracellular concentrations of Ca2þ also
increase TH expression through the cAMP response element-
dependent and independent mechanisms (Nagamoto-Combs
et al., 1997). Moreover, catecholaminergic activation of the
B2AR potentiates glucocorticoid receptor activation (Schmidt
et al., 2001) and the glucocorticoid receptor element is a
noted inducer of TH gene expression (Hagerty et al., 2001a, b)
and PNMT expression (Wong et al., 1998; Tai et al., 2002).
Therefore, it is not unexpected that we observe TH and PNMT
expression to transiently decrease and return to baseline in
concordance with the B2AR expression. However, we find
that activation of the B2AR is needed for downregulation of
TH as TH expression did not modulate in scratch-wounded
cultures where B2AR activation was blocked. However, when
the B2AR eventually decreased in the presence of timolol, the
TH levels continued to remain unchanged from baseline
suggesting that there may be a B2AR-independent pathway
that keeps TH elevated when the B2AR is blocked, even
when the B2AR expression eventually decreased. Appa-
rently, although a post-scratch wound decrease in TH was
completely blocked with the use of B2AR antagonists, post-
scratch decrease in the PNMT expression was only delayed
and not completely blocked with the addition of timolol. This
suggests that the keratinocyte may depend on the presence of
the B2AR for the subsequent synthesis of epinephrine, as
PNMT is the enzyme that generates epinephrine from
norepinephrine. However, as TH levels remained elevated in
the presence of an antagonist to the B2AR, the keratinocyte
seems to selectively prefer downregulation of the capability to
synthesize epinephrine as opposed to norepinephrine. This
is further supported by our finding that norepinephrine levels
preferentially elevate 24hours after scratch wounding,
whereas epinephrine does not (Figure 4a).
Our data demonstrate modulation of norepinephrine, its
receptor, and synthetic enzymes in cultured human keratino-
cytes. To extend the translational significance of these find-
ings, we sampled human skin wound tissue. Skin tissue
harvested in the absence of injected epinephrine, and within
30minutes of surgical injury, was processed for catechol-
amine analysis. Levels range from those reported in non-
stressed muscle (20pgmg1, (Ohkuwa et al., 2005)) to
levels that approximate those found in human serum
(B700ngml1, (Kuebler et al., 2013)). Thus, it is clear that
the wound microenvironment is one wherein norepinephrine
is present, and levels may vary widely. As our data support
a role for norepinephrine in modulating (at least) the
keratinocyte component of healing, it is tempting to suggest
that the variation in norepinephrine within the wound niche
may impact upon healing. We are currently evaluating this
possibility.
Catecholamines generated locally in the wound appear to
impair keratinocyte migration as shown here and previously
(Sivamani et al., 2009b). Elevations in systemic epinephrine,
relative to normal levels, have been found to impair wound
healing in mice (Romana-Souza et al., 2010; Kim et al.,
2014). However, the role of systemic elevation of
norepinephrine is less clear. Although depletion of systemic
norepinephrine impairs healing (Gosain et al., 2006), acute
increases in norepinephrine could impair healing by
decreasing macrophage efficiency in generating micro-
bicidal oxidizing agents (Kuebler et al., 2013). The
differences in the magnitude of the systemic elevation and
the persistence of this elevation may explain the discrepancy,
and future studies will be needed to determine the effects of
stress levels of systemic norepinephrine.
Keratinocytes tightly coordinate their response to wound
stimuli in an autocrine fashion through the B2AR and the
production of catecholamines. Regulation and activation of
the catecholamine pathway and the B2AR occurs through
both B2AR-mediated and B2AR-independent pathways.
In response to the stress of wounding, keratinocytes
acutely decrease their expression of both the B2AR and the
catecholamine-synthesizing enzymes, and this may serve as a
protective response to acutely improve keratinocytes migra-
tory rate and re-epithelialization. Our results suggest that the
catecholamine network in keratinocytes is an important
autocrine pathway in wound-healing physiology, which plays
an active role in the keratinocyte acute wound-healing
response. Norepinephrine, in particular, appears to be an
important endogenous component of the stress-induced
wound microenvironment. The presence and actions of
catecholamines in the wound microenvironment is supported
by reports of therapeutic success with the use of topical
timolol, a beta-adrenergic receptor antagonist (Tang et al.,
2012; Lev-Tov et al., 2013). Fully characterizing the B2AR
autocrine pathway, and now, its newly discovered wound
mediator, norepinephrine, may provide new insights into
therapeutic approaches for improving healing.
MATERIALS AND METHODS
Materials
Isoproterenol was purchased from Calbiochem (San Diego, CA). Anti-
bodies against the B2AR (sc-569) and phenylethanolamine-N-methyl-
transferase (sc-16458) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). The antibody against TH (#2792) was purchased from
Cell Signaling Technology (Danvers, MA) and the antibody against b1
tublin was purchased from Sigma (St Louis, MO). ICI-118,551, norepi-
nephrine, and bisoprolol were purchased from Sigma.
Cell culture and wounding
Human keratinocytes were derived from neonatal foreskins, obtained
with a human subjects protocol approved by the UC Davis Institu-
tional Review Board. Keratinocytes were cultured in Epilife medium
(Cascade Biologics, Portland, OR) that was supplemented with
Human Keratinocyte Growth Supplement (Cascade Biologics) as
RK Sivamani et al.
Keratinocyte Catecholamines in Acute Wounds
www.jidonline.org 2263
described (Pullar et al., 2006b) and incubated at 37 1C in a humidified
atmosphere of 5% CO2.
After cells reached confluence in a 100-mm culture dish, multiple
1-mm wide scratches were made with a sterile pipette. After
wounding, cells were washed with sterile Ca2þ - and Mg2þ -free
phosphate-buffered saline (PBS) multiple times to remove damaged
cells, and then returned to the incubator, and allowed to recover for
various times. Timolol pretreatments were performed for one hour
prior to scratch wounding. Culture dishes of sham control were used
to exclude any effects of the stresses other than wounding, and they
were treated similarly to the experimental cells, except that they were
not scratch-wounded.
Cell lysis and western blot analysis
Cells were lysed as described (McClaren and Isseroff, 1994; Shi and
Isseroff, 1996). Briefly, after treatments the cultures were rinsed with
PBS and scraped in a lysis buffer (10mM Tris, 20mM NaCl, 25mM
sodium fluoride, 1mM EDTA, 1mM EGTA, 1mM dithiothreitol, 2mM
Na3VO4, 1mM phenylmethylsulfonyl fluoride, protease inhibitors, and
pH 7.5). Cell lysates were rocked on ice for 30minutes, and pelleted
at 14,000g for 20minutes. The supernatant was aliquoted and stored
at –80 1C. Protein concentrations in the cell lysates were determined
using the Bradford protein assay (Bio-Rad Laboratories, Hercules, CA).
For western blot analysis, samples with equal amounts of protein
were loaded into a 10 or 7.5% acrylamide gel, and SDS-PAGE was
run at 150mV. The proteins on the gel were transferred onto a
polyvinylidene difluoride membrane at 100mV for 60 or 75minutes.
The membranes were blocked with 5% non-fat dry milk in PBS,
and then probed with appropriate primary antibodies, and also
with antibody against b1 tublin as a protein-loading reference. The
immunoreactive proteins were detected using horseradish peroxi-
dase-linked anti-IgG, and then stained with enhanced chemilumines-
cent western blotting detection reagents (Amersham Life Science,
St Louis, MO). Images were obtained by scanning the films, and
the optical density of each band was determined, and normalized
with the optical density of the loading control b1 tublin using
NIH Image 1.61 (Scion, Bethesda, MD).
Cell migration studies
Cell migration was monitored microscopically as previously des-
cribed (Pullar et al., 2003). Briefly, keratinocytes were plated at a sub-
confluent density of 50 cellsmm 2 onto collagen-coated multi-well
plates (60mgml 1) (Sigma) for 2 hours at 37 1C. The multi-well plate
was then placed into a migration chamber to monitor individual cell
migration in each well over a 1-hour period at 37 1C. The migration
chamber was placed on an inverted Nikon Diaphot (Nikon, Garden
City, NJ) microscope. Time lapse images of the cell migratory paths
were digitally captured by Velocity imaging software (PerkinElmer,
Waltham, MA) every 10minutes for a 1-hour period. Each cell’s
center of mass was tracked in OpenLab (PerkinElmer), the data were
automatically exported to FileMaker Pro 3.0 (FileMaker, Santa Clara,
CA). Data on migration speed for each slide were averaged across
cells measured, so that the data analyzed are statistically
independent. Untreated cells served as the control.
Collection of human wound tissue
Human wound tissue was collected from five subjects who were 52,
60, 63, 64, and 65 years old. The wounds were collected from the
edges of surgical toe amputation sites at the time of the standard
surgical repair, in procedures that had not included any injected
epinephrine prior to excision. Tissue was collected at the viable
wound margin, within 30minutes of skin injury. Immediately upon
release from the wound, tissue samples were snap-frozen in liquid
nitrogen and stored at  80 1C All tissue collection procedures were
approved by the institutional review board at the Veterans Affairs
Medical Center in Mather, CA.
HPLC-elecctrochemical detection analysis of catecholamines
After scratch assays were performed, aspirated cell culture super-
natants and cell lysates were separately acidified with perchloric
acid to a final concentration of 0.2N prior to storage at  80 1C for
future analysis. After thawing 1ml of supernatant, 400ml of HEPES
pH 9.0 buffer, 600ml of neutralization solution (0.33N NaOH;
0.4% sodium sulfite; 0.67mM EDTA), and 5ng of internal
standard 3, 4-Dihdroxybenzylamine (DHBA) was added and then
centrifuged at 14,000g for 5minutes. For cell lysates, 70ml of
thawed lysate was treated with 120ml HEPES pH 9.0 buffer, 1ml of
sulfite solution (1.25% sodium sulfite; 2mM EDTA), and 5ng of
DHBA. After centrifugation, supernatant or lysate solutions were
applied to conditioned MonoSpin PBA solid phase extraction spin
columns (GL Sciences, Torrance, CA). Spin column purifications
were performed according to the manufacturer’s specifications and
catecholamines were eluted in 200ml of 2% acetic acid. Eluents were
then stored at  80 1C for future HPLC electrochemical detection
analyses.
For human wound tissue samples, tissues were removed from a
 80 1C freezer and pulverized using a tissue pulverizer (Cole
Parmer, Vernon Hills, IL) under liquid nitrogen. Pulverized tissue
was then weighed and acidified by adding 250ml of 0.2N perchloric
acid. Acidified solutions were then further homogenized by sonica-
tion (Qsonica, Newtown, CT) and stored at  80 1C for catechola-
mine analysis. After thawing, 1.4ml sulfite solution (1.25% sodium
sulfite; 2mM EDTA) was added to homogenized tissue and centri-
fuged for 5minutes at 3,000g. The supernatant was aspirated and then
treated with 500ml HEPES pH 9.0 buffer and 5ng of DHBA prior to
filtering through a 0.22-um syringe filter. Filtered tissue homogenate
was then applied to conditioned MonoSpin PBA spin columns and
eluted as above.
HPLC separation of samples was performed using a Synergi 4-um
Fusion-reverse phase 250 4.6-mm column (Phenomenex, Torrance,
CA) and a Hewlett Packard series 1050 pump and auto injector
system. The column temperature was maintained at 28 1 C and data
were acquired using Chem Station software. Chromatographic
separation was performed using a mobile phase that was modified
from Leis et al. (Leis et al., 2004) and consisted of 50mM citric
acid, 0.1M sodium acetate, 0.15mM EDTA, 1mM sodium
1-octanesulfonate, and 4% methanol, pH 4 and was pumped at a
flow rate of 1ml per min. Detection of catecholamine compounds
was performed using a LC-4C amperometric detector (Bioanalytical
Systems, West Lafayette, IN) using potential of  700mV.
Commercially purchased standards were used for calibration of the
instrument (norepinephrine, Sigma; epinephrine, MP Biomedicals
(Santa Ana, CA); 3,4-dihydroxyphenyl glycol or DOPEG; Sigma;
and DHBA, Sigma). Standard curves were generated for each
compound (ranging from 4,000 to 4pg) with correlation coefficients
(R2) near 1.0 for all compounds.
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Radioligand binding
The hydrophilic non-selective beta-adrenergic antagonist
[3H]CGP12177 (PerkinElmer) was used as radioligand for whole-cell
binding assays. All assays were carried out in triplicate. Normal
human keratinocytes from neonates were cultured to confluency in
500-cm2 square dishes (Sigma-Aldrich, Catalog #CLS431110-16EA).
Once confluent, cultures were scratch wounded with a comb,
washed three times with PBS followed by replacement of medium
until time for cell harvest with 0.25% trypsin/EDTA. Control cultures
were similarly washed with PBS followed by addition of fresh
medium. Cells were counted using trypan blue exclusion and
resuspended in medium at 5 106 cells per ml. Binding was
measured by a modified method as previously reported (Steinkraus
et al., 1991). Total binding was determined by aliquoting 150ml of
cell suspension (5 106 cells per ml), 50ml of [3H]CGP12177, and
50ml of medium. Non-specific binding was determined by aliquoting
150ml of cell suspension (5 106 cells per ml), 50ml of
[3H]CGP12177, and 50ml of propranolol at a final volume of 5mM.
Both curves yield 250ml total volume for each varying hot compound
concentration. [3H]-CGP12177 was serially diluted in a range from
0.03 to 8nM in 50ml within the 250ml total volume. Incubation was
for 90minutes in a shaking water bath at 37 1C. Termination of
reaction was performed using rapid vaccum filtation using Whatman
GF/C glass fiber filter and ice-cold harvest buffer (50mM Tris HCl,
10mM MgCl2: pH¼ 7.4). Radioactivity was determined by liquid
scintillation spectrometry. Results were analyzed using GraphPad
Prism (GraphPad Software, La Jolla, CA) software to determine
specific binding and Scatchard transformation.
Statistical analysis
These data were analyzed using one-way analysis of variane and
P-values less than 0.05 were taken to be statistically significant.
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